Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Drug Design, Development and Therapy|December 15, 2010
Profile of belatacept and its potential role in prevention of graft rejection following renal transplantationGaurav Gupta, Karl L WomerCellular Immunology|October 19, 2007
Ischemia-reperfusion and immediate T cell responsesYanfei Huang, Hamid Rabb, Karl L WomerJournal of Immunological Methods|November 3, 2015
Effects of mesenchymal stromal cells on human myeloid dendritic cell differentiation and maturation in a humanized mouse modelPing Chen, Yanfei Huang, Karl L WomerAnnual Review of Medicine|September 28, 2006
Why hasn't eliminating acute rejection improved graft survival?JogiRaju Tantravahi, Karl L Womer, Bruce KaplanJournal of Immunology (Baltimore, Md. : 1950)|April 20, 2007
Clinical transplantation tolerance: many rivers to crossAlan D Salama, Karl L Womer, Mohamed H SayeghJournal of Transplantation|January 10, 2018
Analysis of Risk Factors for Kidney Retransplant Outcomes Associated with Common Induction Regimens: A Study of over Twelve-Thousand Cases in the United StatesAlfonso H Santos, Michael J Casey, Karl L WomerImmunologic Research|January 19, 2010
Immunologic research in kidney ischemia/reperfusion injury at Johns Hopkins UniversityGang Jee Ko, Asif Zakaria, Karl L Womer, et al.Transplantation|January 26, 2017
Association of Baseline Viral Serology and Sirolimus Regimens With Kidney Transplant Outcomes: A 14-Year Registry-Based Cohort Study in the United StatesAlfonso H Santos, Michael J Casey, Wen Xuerong, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 19, 2017
New-onset diabetes after kidney transplantation: can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology?Alfonso H Santos, Chao Chen, Michael J Casey, et al.Journal of the American Society of Nephrology : JASN|October 25, 2001
Indirect allorecognition of donor class I and II major histocompatibility complex peptides promotes the development of transplant vasculopathyKarl L Womer, James R Stone, Barbara Murphy, et al.Pageof 3